Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
NBA approves record $10B sale of Lakers to Walter, a high-spending sports owner who will work with Jeanie Buss to maintain the franchise's excellence.
Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
NBA approves record $10B sale of Lakers to Walter, a high-spending sports owner who will work with Jeanie Buss to maintain the franchise's excellence.